Chemoinformaics analysis of Scuterivulactone D
| Molecular Weight | 470.562 | nRot | 4 |
| Heavy Atom Molecular Weight | 436.29 | nRig | 24 |
| Exact Molecular Weight | 470.23 | nRing | 4 |
| Solubility: LogS | -4.076 | nHRing | 1 |
| Solubility: LogP | 3.178 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 68 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 34 | No. of Aromatic Carbocycles | 1 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 27 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 6 |
| nHA | 7 | APOL | 73.375 |
| nHD | 3 | BPOL | 39.317 |
| QED | 0.5 |
| Synth | 5.006 |
| Natural Product Likeliness | 1.556 |
| NR-PPAR-gamma | 0.614 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.047 |
| Pgp-sub | 0.766 |
| HIA | 0.02 |
| CACO-2 | -5.213 |
| MDCK | 0.0000148 |
| BBB | 0.846 |
| PPB | 0.965556 |
| VDSS | 0.76 |
| FU | 0.0676466 |
| CYP1A2-inh | 0.178 |
| CYP1A2-sub | 0.205 |
| CYP2c19-inh | 0.09 |
| CYP2c19-sub | 0.156 |
| CYP2c9-inh | 0.295 |
| CYP2c9-sub | 0.842 |
| CYP2d6-inh | 0.158 |
| CYP2d6-sub | 0.106 |
| CYP3a4-inh | 0.605 |
| CYP3a4-sub | 0.277 |
| CL | 10.163 |
| T12 | 0.728 |
| hERG | 0.232 |
| Ames | 0.005 |
| ROA | 0.554 |
| SkinSen | 0.599 |
| Carcinogencity | 0.09 |
| EI | 0.307 |
| Respiratory | 0.957 |
| NR-Aromatase | 0.84 |
| Antiviral | Yes |
| Prediction | 0.914905 |